1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Medicover AB (publ)

Medicover AB (publ)

MCVEY
Medicover AB (publ)US flagOther OTC
16.55
USD
- -
- -
2.50BMarket Cap
Medicover AB (publ)
MCVEY
(Other OTC)

Recent

price

16.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.74
3.12
5.23
4.87
5.04
6.33
7.04
9.28
10.16
11.69
13.95
15.78
15.03
Revenue per Share
0.03
0.06
0.05
0.16
0.17
0.17
0.18
0.69
0.08
0.12
0.11
0.51
0.29
Basic EPS, GAAP
-0.01
-0.02
-0.87
0.18
-0.06
-0.29
0.58
0.77
0.2
0.63
0.93
1.23
1.05
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.07
0.12
0.12
0.12
0.15
0.15
Dividend per Share
0.46
0.52
0.84
0.09
0.25
0.39
0.57
1.16
1.04
1.07
0.69
1.08
0.81
Book Value per Share
-0.16
-0.24
-0.54
1.15
0.87
-0.09
0.92
0.78
-0.76
-0.74
-1.12
-1.78
-2.11
Tangible Book Value per Share
133
133
95
119
133
133
142
148
149
149
150
151
150
Basic Weighted Avg Shares
365
416
497
580
672
844
998
1,377
1,510
1,746
2,092
2,378
2,258
Sales/Revenue/Turnover
4.6
5.17
4.24
4.96
5.02
5.54
6.59
11.57
3.75
3.5
4.14
6.55
4.77
Operating Margin (%)
18
18
23
26
57
74
96
111
162
183
198
215
222
Depreciation Expense
4
8
4
19
22
22
26
102
12
18
17
78
43
Net Income, GAAP
63.57
46.11
47.15
27.86
23.66
25.83
26.81
25.87
29.74
22.03
27.36
26.12
28.31
Effective Tax Rate (%)
1.18
1.8
0.86
3.22
3.32
2.66
2.59
7.39
0.78
1.01
0.8
3.26
1.92
Profit Margin (%)
-72
39
37
36
59
-66
61
227
-22
-119
-120
-211
-69
Working Capital
- -
126
195
138
223
306
318
675
838
775
981
1,095
1,187
LT Debt
90
93
99
300
318
360
484
562
508
528
489
545
485
Total Equity
- -
5.46
4.12
5.24
4.87
4.98
5.75
10.68
2.82
3.16
3.83
6.13
4.29
Return on Invested Capital (%)
- -
4.11
1.82
8.58
11.51
7.25
7.29
15.28
3.23
4.89
4.8
8.69
6.52
Return on Capital (%)
- -
11.51
5.79
41.19
99.33
52.39
38.77
80.57
7.22
11.19
12.68
58.03
31.61
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
258
248
237
LT Borrowings
543
560
746
LT Finance Leases
438
437
441
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
150
150
151
Market Capitalization
2,396
2,296
2,110

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
447
481
477
Cash, Cash Equivalents & STI
83
113
89
Accounts Receivable, Net
212
306
329
Inventories
69
62
59
Total Current Liabilities
566
565
546
Payables & Accruals
- -
- -
- -
ST Debt
258
248
237
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.76%
2.92%
11.36%
Free Cash Flow
394.41%
52.88%
32.95%
Net Income, GAAP
94.13%
122.85%
364.07%
Sales/Revenue/Turnover
19.28%
19.36%
13.69%
Total Cash Common Dividend
- -
- -
25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
499
509
528
556
2,092
2025
578
597
612
- -
2,378
2026
624
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.04
-0.03
0.06
0.11
2025
0.13
0.13
0.12
- -
0.51
2026
0.15
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.12
- -
- -
0.12
2025
- -
0.15
- -
- -
0.15
2026
- -
- -
- -
- -
- -
Similar Companies
Rennova Health, Inc. (RNVAW)
Dental Corporation Public Company Limited (D.BK)
Fresenius SE & Co. KGaA (FRE.DE)
Ardent Health Inc. (ARDT)
Xi'an International Medical Investment Company Limited (000516.SZ)
AS Partners Co. Ltd. (160A.T)
Business
Medicover AB (publ) (MCVEY) operates as an international healthcare and diagnostic services provider primarily in Central and Eastern Europe, with significant presence in Poland, Germany, Romania, India, Sweden, Turkey and other countries including Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, Cyprus, Slovenia, Croatia and North Macedonia. Founded in 1995 and headquartered in Stockholm, Sweden, the company delivers integrated healthcare solutions through two main segments: Healthcare Services and Diagnostic Services. Healthcare Services offers outpatient and inpatient care including specialist consultations, hospital care, primary care, fertility treatments, state-of-the-art dental services, optician services, mental health services, pharmacies, wellness solutions such as sports memberships, benefit cards, optics and preventive care; Diagnostic Services provides a comprehensive range of laboratory tests encompassing allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics and transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology and toxicology, conducted via numerous clinical laboratories, blood-drawing points and clinics. The company serves corporate clients, private individuals, patients and public payers, operating over 180 medical centres, 40 hospitals, 115 dental centres, 38 optical showrooms, 18 fertility clinics, 144 fitness clubs, 97 clinical laboratories and 733 blood-drawing points across its markets, supported by more than 47,000 employees. In April 2025, Medicover acquired SYNLAB Group's local diagnostic businesses in Romania, Turkey, Cyprus, Slovenia, Croatia and North Macedonia for EUR 71.3 million including net debt, adding 25 laboratories, 80 blood-drawing points, EUR 48 million in 2024 revenue and 675 staff while entering three new markets and expecting synergies exceeding 50% of acquired profitability within 12 months through integration, advanced testing centralization and procurement efficiencies; the deal, financed via existing facilities, became EPS accretive upon consolidation from 1 April 2025. Recent initiatives also encompass digital healthcare enhancements like telemedicine and AI integration for operational efficiency, alongside expansion plans through its Indian subsidiary including new multi-speciality hospitals in Hyderabad, Pune and Bengaluru targeting over 6,300 beds by fiscal 2026 and an initial public offering in 2026.

Company News

APIChatGPT

  • seekingalpha.com

    Medicover AB (publ) (MCVEY) Q1 2026 Earnings Call Transcript